Skip to content

Clinical trials

Phase 4 Cardiomyopathy, Hypertrophic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Phase: Phase 4 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20171
20181
20201
20211
20222
20231
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Recruiting3
Completed3
Terminated1
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University2
Bristol-Myers Squibb1
China National Center for Cardiovascular Diseases1
Meshalkin Research Institute of Pathology of Circulation1
Morten Steen Kvistholm Jensen1
Oregon Health and Science University1
Second Affiliated Hospital of Nanchang University1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Tufts Medical Center1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic14
Fibrosis2
Chest Pain1
Dyspnea1
Ventricular Outflow Obstruction, Left1

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.